Wikidata

(Q83523403)

English

Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR)

scientific article published on 27 February 2012

In more languages
default for all languages
No label defined

No description defined

Statements

title
Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22370318
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22370318%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q83523403&oldid=1713477435"